Literature DB >> 12098039

Primary hyperparathyroidism: renal calcium excretion in patients with and without renal stone sisease before and after parathyroidectomy.

Vibe G Frøkjaer1, Charlotte L Mollerup.   

Abstract

The effect of parathyroidectomy on renal calcium excretion per 24 hours in patients with primary hyperparathyroidism with and without a history of renal stone disease was evaluated. Altogether, 91 patients operated on for primary hyperparathyroidism formed the study group for preoperative analysis. Of these patients, 42 were evaluated 1 to 3 years postoperatively. The median preoperative serum calcium level was 2.92 mmol/L, and it was the same for patients with or without renal stones. Preoperatively we found no differences in renal calcium excretion between patients with and without renal stone disease. The median renal calcium excretion was 6.80 mmol/24 hr. At 1 to 3 years after successful parathyroidectomy the group with renal stone disease had higher renal calcium excretion than the group without renal stones (p = 0.03). The reduced effect of parathyroidectomy on renal calcium excretion in the patients with renal stone disease indicates that factors not related to the hyperparathyroid state could contribute to disturbances in renal calcium excretion and hence stone formation. In conclusion, the pathologic basis for renal stone formation in patients with primary hyperparathyroidism might not be the hyperparathyroid state alone; stone formation could be related to other predisposing factors as well. Therefore, although parathyroidectomy can cure hyperparathyroidism, the curative effect on renal stone disease should be reconsidered.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12098039     DOI: 10.1007/s00268-001-0262-6

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  14 in total

Review 1.  The pathogenesis and treatment of kidney stones.

Authors:  F L Coe; J H Parks; J R Asplin
Journal:  N Engl J Med       Date:  1992-10-15       Impact factor: 91.245

Review 2.  Clinical spectrum of primary hyperparathyroidism: evolution with changes in medical practice and technology.

Authors:  H Heath
Journal:  J Bone Miner Res       Date:  1991-10       Impact factor: 6.741

3.  Nephrolithiasis and bone involvement in primary hyperparathyroidism.

Authors:  S J Silverberg; E Shane; T P Jacobs; E S Siris; F Gartenberg; D Seldin; T L Clemens; J P Bilezikian
Journal:  Am J Med       Date:  1990-09       Impact factor: 4.965

4.  A lack of unique pathophysiologic background for nephrolithiasis of primary hyperparathyroidism.

Authors:  C Y Pak; M J Nicar; R Peterson; J E Zerwekh; W Snyder
Journal:  J Clin Endocrinol Metab       Date:  1981-09       Impact factor: 5.958

5.  Population-based screening for primary hyperparathyroidism with serum calcium and parathyroid hormone values in menopausal women.

Authors:  E Lundgren; J Rastad; E Thrufjell; G Akerström; S Ljunghall
Journal:  Surgery       Date:  1997-03       Impact factor: 3.982

6.  Primary hyperparathyroidism. Low surgical morbidity supports liberal attitude to operation.

Authors:  M Kjellman; K Sandelin; L O Farnebo
Journal:  Arch Surg       Date:  1994-03

7.  The natural history of renal stone disease after parathyroidectomy for primary hyperparathyroidism.

Authors:  N Jabbour; J Corvilain; M Fuss; P Kinnaert; J Van Geertruyden
Journal:  Surg Gynecol Obstet       Date:  1991-01

8.  Infrequency of primary hyperparathyroidism in renal stone formers.

Authors:  M Fuss; T Pepersack; J Corvilain; J C Vandewalle; J Van Geertruyden; J Simon; P Kinnaert
Journal:  Br J Urol       Date:  1988-07

9.  Effect of parathyroidectomy on crystallization of calcium salts in urine of patients with primary hyperparathyroidism.

Authors:  C Y Pak
Journal:  Invest Urol       Date:  1979-09

Review 10.  Primary hyperparathyroidism in younger and older patients: symptoms and outcome of surgery.

Authors:  P Udén; A Chan; Q Y Duh; A Siperstein; O H Clark
Journal:  World J Surg       Date:  1992 Jul-Aug       Impact factor: 3.352

View more
  10 in total

1.  Occult urolithiasis in asymptomatic primary hyperparathyroidism.

Authors:  Yu-Kwang Donovan Tay; Minghao Liu; Leonardo Bandeira; Mariana Bucovsky; James A Lee; Shonni J Silverberg; Marcella D Walker
Journal:  Endocr Res       Date:  2018-02-05       Impact factor: 1.720

2.  Recurrent urolithiasis following parathyroidectomy for primary hyperparathyroidism.

Authors:  C Rowlands; A Zyada; S Zouwail; H Joshi; M J Stechman; D M Scott-Coombes
Journal:  Ann R Coll Surg Engl       Date:  2013-10       Impact factor: 1.891

3.  Risk factors associated to kidney stones in primary hyperparathyroidism.

Authors:  S Corbetta; A Baccarelli; A Aroldi; L Vicentini; G B Fogazzi; C Eller-Vainicher; C Ponticelli; P Beck-Peccoz; A Spada
Journal:  J Endocrinol Invest       Date:  2005-02       Impact factor: 4.256

4.  Risk of renal stone events in primary hyperparathyroidism before and after parathyroid surgery: controlled retrospective follow up study.

Authors:  Charlotte L Mollerup; Peter Vestergaard; Vibe Gedsø Frøkjaer; Leif Mosekilde; Peer Christiansen; Mogens Blichert-Toft
Journal:  BMJ       Date:  2002-10-12

5.  Persistence of hypercalciuria after successful surgical treatment for primary hyperparathyroidism.

Authors:  Francisco Rodolfo Spivacow; Armando Luis Negri; Elisa Elena del Valle; Erich Fradinger; Carolina Martinez; Ana Polonsky
Journal:  Int Urol Nephrol       Date:  2011-04-20       Impact factor: 2.370

6.  Effect of parathyroidectomy on renal stone recurrence.

Authors:  Pierre-Yves Charles; Emmanuel Letavernier; Sophie Périé; Mathieu Gauthé; Michel Daudon; Jean-Philippe Haymann
Journal:  Urolithiasis       Date:  2021-01-09       Impact factor: 3.436

7.  Renal manifestations of primary hyperparathyroidism.

Authors:  Anurag Ranjan Lila; Vijaya Sarathi; Varsha Jagtap; Tushar Bandgar; Padma S Menon; Nalini Samir Shah
Journal:  Indian J Endocrinol Metab       Date:  2012-03

Review 8.  Primary hyperparathyroidism: review and recommendations on evaluation, diagnosis, and management. A Canadian and international consensus.

Authors:  A A Khan; D A Hanley; R Rizzoli; J Bollerslev; J E M Young; L Rejnmark; R Thakker; P D'Amour; T Paul; S Van Uum; M Zakaria Shrayyef; D Goltzman; S Kaiser; N E Cusano; R Bouillon; L Mosekilde; A W Kung; S D Rao; S K Bhadada; B L Clarke; J Liu; Q Duh; E Michael Lewiecki; F Bandeira; R Eastell; C Marcocci; S J Silverberg; R Udelsman; K Shawn Davison; J T Potts; M L Brandi; J P Bilezikian
Journal:  Osteoporos Int       Date:  2016-09-09       Impact factor: 4.507

9.  Biochemical characterization of primary hyperparathyroidism with and without kidney stones.

Authors:  Clarita V Odvina; Khashayar Sakhaee; Howard J Heller; Roy D Peterson; John R Poindexter; Paulette K Padalino; Charles Y C Pak
Journal:  Urol Res       Date:  2007-05-03

Review 10.  Diagnosis, management, histology and genetics of sporadic primary hyperparathyroidism: old knowledge with new tricks.

Authors:  Maria Mizamtsidi; Constantinos Nastos; George Mastorakos; Roberto Dina; Ioannis Vassiliou; Maria Gazouli; Fausto Palazzo
Journal:  Endocr Connect       Date:  2018-01-12       Impact factor: 3.335

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.